EndoChoice has announced it has completed a $43 million venture capital round of funding led by Sequoia Capital.

EndoChoice, headquartered in Alpharetta, Ga. provides devices, diagnostics, infection control and imaging for specialists treating gastrointestinal diseases. 

DowJones reported that Sequoia Capital was joined by returning EndoChoice backers Council Ventures, EnVest and River Cities Capital Funds for the Series D round of funding.